See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Invesco QQQ (QQQ) - free report >>
SPDR S&P 500 ETF (SPY) - free report >>
SPDR Dow Jones Industrial Average ETF (DIA) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invesco QQQ (QQQ) - free report >>
SPDR S&P 500 ETF (SPY) - free report >>
SPDR Dow Jones Industrial Average ETF (DIA) - free report >>
Image: Bigstock
International Bond and Biotech: 2 ETFs to Watch on Outsized Volume
The last trading session has been a mixed one for U.S. stocks. Among the top ETFs, (SPY - Free Report) gained about 0.1% while (DIA - Free Report) and (QQQ - Free Report) moved 0.1% and 0.2% lower on the day.
Two other specialized ETFs are also worth watching as both saw higher-than-normal trading volume. In fact, both the funds experienced volume levels that were more than double their average for most part of the last trading session. This could make these ETFs the ones to watch out for in the days ahead to see if the trend continues.
BNDX: Volume 3.49 times average
This international total bond market ETF was closely watched yesterday as about 7.88 million shares changed hands. This compares to the average trading volume of around 2.23 million shares and BNDX lost about 0.07% in the session.
The big move was probably the result of a slight uptick in yields amid the possibility of aversion in another U.S. shutdown and U.S.-China trade talks. The fund has added about 1.2% in the past month.
BIB: Volume 3.22 times average
This double-leveraged biotech ETF was in the spotlight yesterday as nearly 633,000 shares moved hands compared with an average of roughly 196,800 shares a day. The fund gained about 1.2% in the last trading session.
The movement can largely be credited to the BioRestorative Therapies’ developing of a therapy ''ThermoStem.'' The news along with other sector-specific tailwinds like strong merger and acquisitions and increased demand for drugs in the developing markets led to the uptick in volume. For the month, IBB is down about 0.6%.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >